Keros Therapeutics, Inc.

Q2 2021 13F Holders

Symbol
KROS
CUSIP
492327101
Type
Equity
Class
COM
Num filings
81
Total reported value, excl. options
$600 M
Manager Report Date Value ($000) Shares Option Type